12202770.txt 0 defects   interstrand crosslink uncoupling     account     extreme sensitivity   ercc1   xpf cells   cisplatin
12202770.txt 1   anticancer drug cisplatin reacts   dna leading     formation   interstrand   intrastrand crosslinks       critical cytotoxic lesions   contrast   cells bearing mutations   other components     nucleotide excision repair apparatus xpb xpd xpg   csb cells defective     ercc1xpf structurespecific nuclease   highly sensitive   cisplatin   determine     extreme sensitivity   xpf   ercc1 cells   cisplatin results   specific defects     repair   either intrastrand   interstrand crosslinks   measured   elimination   both lesions     range   nucleotide excision repair chinese hamster mutant cell lines including xpf   ercc1defective cells compared     parental repairproficient cell line     mutants tested were defective     elimination   both classes   adduct despite their very different levels   increased sensitivity consequently       clear relationship between initial incisions   interstrand crosslinks   removal   intrastrand adducts   cellular sensitivity these results demonstrate     high cisplatin sensitivity   ercc1   xpf cells likely results     defect other than   excision repair   contrast   other conventional dna crosslinking agents   found     repair   cisplatin adducts does   involve   formation   dna doublestrand breaks surprisingly xrcc2   xrcc3 cells   defective     uncoupling step   cisplatin interstrand crosslink repair suggesting   homologous recombination might   initiated prior   excision     type   crosslink
12202770.txt 2 
12202770.txt 3   anticancer drug cisplatin reacts     n7 atom   purine bases   forms several types   dna adduct including dna interstrand crosslinks icls   12   13intrastrand crosslinks  although cisplatin has been widely used   cancer chemotherapy   many years   critical cytotoxic dna lesion induced     drug   still debated evidence   both 12intrastrand crosslinks    icls      critical dna lesion has been presented   repair   cisplatin intrastrand adducts has been studied   detail using substrates containing defined sitespecific crosslinks   cell extracts   purified repair proteins     three major cisplatin intrastrand crosslinks 12 gpg 12 apg   13dgpnpg     substrates     mammalian nucleotide excision repair ner apparatus    12cisplatin adducts   however much   poorly recognised adding support     argument         critical cytotoxic lesion    less efficient repair   12intrastrand adducts   believed   result     smaller degree   helical distortion these crosslinks induce    contrast very little   known about   repair   cisplatin icls   form between guanines     complementary dna strands   number   recent   vitro     vivo studies indicate   specialised repair reactions might incise one strand     crosslinked dna   therefore uncouple   icls formed     nitrogen mustard mechlorethamine    those induced following psoralen plus uva treatment  initiating repair these reactions   dependent     action     xpf   ercc1 proteins     other members     mammalian ner apparatus   ercc1   xpf form   tight heterodimeric complex   possesses endonuclease activity     junctions between singlestranded   doublestranded dna  two different reactions have been described   biochemical studies     action     complex   dna containing defined icls   first reaction involves   35 degradation     dna surrounding   icl   one strand   xpf ercc1     presence   rpa leaving   single uncoupled adducted nucleotide  attached     complementary strand   second involves incisions     xpf ercc1 complex 5   3     icl uncoupling   crosslink    second reaction requires     icl bears an unpaired region located immediately 3     icl     was suggested   such structures arise during replication   contribute   icl repair during   s phase     cell cycle very recently   has been demonstrated   human mutsbeta might   involved     recognition   uncoupling step   psoralen icl repair  chinese hamster ovary cho cell lines defective   xpf   ercc1   extremely sensitive   cisplatin    contrast   cells defective   other components     ner apparatus   agents such   mechlorethamine   psoralen plus uva   seems likely   arise   least partly   an inability   uncouple   icls produced   these agents     pathways outlined above   however another possible explanation     ercc1   xpf cells   sensitive because   have   dual defect   both   excision repair   crosslinks     homologous recombination homologous recombination   known     an important factor determining survival following treatment   crosslinking drugs  importantly   saccharomyces cerevisiae homologues   xpf   ercc1 rad1   rad10   required     singlestrand annealing subpathway   homologous recombination            evidence     role     mammalian ercc1 xpf complex   homologydriven recombination     sought   understand   extreme sensitivity   mammalian xpf   ercc1 cells   cisplatin measure ments     repair capacity     two candidate critical lesions icls   12intrastrand crosslinks indicated   although both   reduced   xpf   ercc1 cells these processes were also defective   other ner mutants consequently excision repair defects     seem   account     extreme sensitivity   ercc1   xpf cells   cisplatin       contrast   other crosslinking agents such     nitrogen mustard mechlorethamine where specific defects   icl uncoupling   appear     responsible     sensitivity   ercc1   xpf cells 
12202770.txt 4 cell lines   culture conditions    cell lines used     study   listed   table    aa8 uv23 uv42 uv61   uv96 cell lines were obtained   dr m stefanini istituto di genetica biochimica et evoluzionistica pavia italy while uv135 was purchased     american tissue culture collection   v79 irs1 irs1sf chok1   xrs5 cell lines were kindly provided   prof j thacker mrc radiation   genome stability unit harwell uk   cell lines were grown   monolayers   f12   hepes medium sigma poole uk supplemented   2 mm glutamine   10 foetal calf serum fcs cells were grown   37c     5 co2 incubator trypsin versine solution was used   detach cells  chemicals   enzymes  cisplatin 100 mg 100 ml injectable aqueous stock solution containing 900 mg 100 ml sodium chloride   100 mg 100 ml mannitol was obtained   david bull laboratories australia analytical grade mechlorethamine nitrogen mustard   hn2 was purchased   sigma   enzymes used were purchased   promega uk  cytotoxicity assay  cytotoxicity was determined using   srb growth inhibition assay described   detail previously   determination   dna interstrand crosslinking using   comet assay    was determined using   modification     comet assay  exponentially growing cells were treated     desired concentrations   cisplatin   fcsfree medium   1 h   37c   reduce binding   serum protein   medium was replaced   fresh complete medium   incubation continued     required postincubation time cells were   trypsinised   diluted     density   25 x 104 cells ml   kept   ice   drugtreated samples plus one control were subjected   125 gy xirradiation   ice   an unirradiated control was included microscope slides were precoated   1 w v typeia agarose   05 ml   cells were mixed   1 ml   1 w v typevii agarose   spread over   precoated slide   duplicate   coverslip was added     agarose was allowed   solidify   coverslips were removed     slides were placed   lysis solution 100 mm na2edta 25 m nacl 10 mm tris hcl ph 105 containing 1 triton x100   4c   incubated   1 h     dark   slides were subsequently washed   icecold water   15 min     was repeated three times   slides were   transferred   an electrophoresis tank containing icecold alkaline solution 50 mm naoh 1 mm na2edta ph 125   incubated   45 min     dark electrophoresis was carried out   25 min   18 v 06 v cm 250 ma     dark slides were removed   1 ml   neutralising solution 05 m tris hcl ph 75 was added   incubated   10 min each slide was rinsed twice   1 ml   phosphatebuffered saline pbs   allowed   dry overnight   room temperature slides were stained   25 microg ml propidium iodide   comets were analysed using   nikon diaphot tdm inverted epifluorescent microscope consisting     high pressure mercury vapour light source   580 nm dichroic mirror   510 560 nm excitation filter     590 nm barrier filter   20x magnification fifty cells were analysed per slide using komet assay software kinetic imaging liverpool uk   degree   dna interstrand crosslinking present     drugtreated sample was determined   comparing   tail moment     irradiated drugtreated samples   irradiated untreated samples   unirradiated untreated samples    level   interstrand crosslinking   proportional     decrease   tail moment dtm     irradiated drugtreated sample compared     irradiated untreated control   dtm   calculated     following formula  dtm  1   tmdi   tmcu tmci   tmcu x 100 where tmdi     mean tail moment     drugtreated irradiated sample tmci     mean tail moment     irradiated control sample   tmcu     mean tail moment     unirradiated control sample  measurement   cisplatin intrastrand crosslinks   elisa  exponentially growing cells were treated   cisplatin   1 h   incubated   drugfree medium   various times   assayed immediately cells were washed   pbs twices   genomic dna was isolated using   qiagen genomic dna tip genomic dna was digested   hindiii ethanol precipitated   resuspended   water   dna concentration was determined fluorimetrically   competitive elisa developed   tilby et al  was used   certain modifications elisa plates highbind 96well flat bottom greiner were prepared   day before   coating   wells   platinated dna denatured calf thymus dna treated   cisplatin   give an adduct level   352 microm g dna provided   m j tilby university   newcastle uk was diluted 12000   coating buffer 1 m sodium chloride 50 mm sodium phosphate 002 sodium azide   50 microl     solution was incubated   each well   37c overnight elisa wells were   blocked   150 microl well bsa solution 1 w v   pbs     least 30 min   room temperature assay samples     standard kindly provided   m j tilby were incubated   boiling water   5 min   increase immunoreactivity   serially diluted   db buffer 50 mm sodium chloride 50 mm sodium phosphate ph 70 icr4 antibody was diluted 160 000   pbs containing 02 bsa 90 mm sodium chloride 02 tween20   02 mg ml phenol red   55 microl     solution was mixed   55 microl   serially diluted assay samples     standard after 30 min incubation   37c 50 microl aliquots were transferred   coated 96well elisa plates   incubated   1 h   37c   samples were assayed   duplicate each assay plate included wells without sample only antibody   wells without antibody only sample standard following five washes   pbs containing 01 v v tween20 bound antibody was determined using 50 microl well biotinylated goat antirat antibody sigma diluted 12500   pbs containing 1 bsa 02 tween20 following 30 min incubation   37c plates were washed three times   pbs containing 01 v v tween20   wells were incubated   50 microl   streptavidin betagalactosidase reagent boehringer stock dissolved   1 ml   pbs   diluted 110 000   pbs containing 10 mm mgcl2 1 bsa   01 tween20 following 30 min incubation   37c plates were washed seven times   incubated   50 microl well 4methylumbelliferyl beta galactoside sigma 80 microg ml solution made   pbs containing 10 mm mgcl2   azide plates were covered   placed     dark   2 4 h   measure   fluorescence   each well plates were read   360 nm emission   465 nm excitation using   tecan spectrafluor plus plate reader   mean background reading was subtracted       readings     percentage inhibition   maximum fluorescence was calculated   each serial dilution     assay samples     standard cisplatin intrastrand adduct levels were   calculated   described   tilby et al   analysis   doublestrand breaks dsbs   pulsed field gel electrophoresis pfge  cells growing     monolayer were treated   cisplatin   1 h washed   10 ml   pbs   incubated   fresh medium     required repair time cells were trypsinised 3 x 106 cells were harvested   pfge plugs were prepared using   biorad mammalian chef genomic plug kit   instructed     manufacturer pfge was performed     07 gel pulse field certified agarose biorad   025x tbe buffer using   biometra rotaphor type v apparatus electrophoresis runs were   120 h   14c     following parameters interval 5000 1000 s log angle 110 100 linear voltage 50 45 v linear   completion   gels were stained   2 microg ml ethidium bromide   1 h destained overnight   water   photographed semiquantitative data were obtained   measuring   absolute integrated optical density   each lane using gel pro analyser media cybernetics   calculating   percentage   dna released     dna plug  table 1  chinese hamster cell lines used     study
12202770.txt 5 ercc1   xpf cells   highly sensitive   cisplatin  exponentially growing cells were treated   increasing concentrations   cisplatin   1 h   growth inhibition measured using   srb assay   shown   figure    uv47   uv96 cell lines defective   xpf   ercc1 respectively showed extreme sensitivity   cisplatin compared   their isogenic parent cell line aa8 when ic50 values were compared xpf   ercc1 mutants were 40   37fold   sensitive   cisplatin than their parent cell line indicating   crucial role     structurespecific nuclease     repair   cisplatininduced dna damage   contrast   xpb xpd   xpg mutant cells were only 14 13   31fold   sensitive than   parent cell line respectively suggesting   minor role   these ner proteins     response   critical cisplatin lesions  induction   repair   dna icls  dna icls     potentially cytotoxic    quantitatively minor adduct similar1     total lesions formed   cisplatin  using   modification     comet assay   permits detection   icls     single cell level   vivo   induction   repair kinetics   cisplatininduced icls were studied prior   cell lysis   cells receive   fixed dose   xrays   induce random strand breakage   presence   icls retards migration     irradiated dna during electrophoresis resulting     reduced tail moment compared     nondrugtreated control figure   shows   percentage decrease   tail moment   increasing concentrations   cisplatin     parental repairproficient aa8 cell line   decrease   tail moment occurs linearly up   30 microm     further significant increase was observed   50 microm   singlestrand breaks were seen   unirradiated samples treated   increasing doses   cisplatin data   shown   kinetics   icl induction   repair     ner mutants were examined following   1 h treatment   50 microm cisplatin fig b   dose gives 50 inhibition   growth   aa8 cells   induces   readily detectable level   icls similar40 decrease   tail moment   previously reported  icl levels peak   similar8 h followed   gradual repair     still incomplete   72 h posttreatment incubation aa8   its isogenic ner mutant derivatives xpb xpg xpf   ercc1 were treated   50 microm cisplatin   1 h     level   icls assessed following 0 24 48   72 h postincubation   drugfree medium fig c   comparable level   icls was observed     these cell lines immediately following   1 h treatment demonstrating     differences   sensitivity     due   differences     induction   icls consistent   their extreme sensitivities   xpf   ercc1 mutants were defective     uncoupling step   incision   cisplatininduced icls surprisingly   much less sensitive xpb   xpg mutants were also defective     uncoupling   icls   lack   correlation between sensitivity   cisplatin   icl incision capacity implies     differential sensitivities     ner mutants   cisplatin     due     difference   their ability   initiate repair     icls induced     drug  induction   repair   cisplatin 12intrastrand crosslinks  since   definite correlation was observed between cisplatin sensitivity     uncoupling   icls   any     ner mutants   induction   repair   intrastrand cisplatin adducts was investigated     parent   ner mutant cell lines these adducts were measured using   competitive elisa method developed   tilby et al  employing   monoclonal antibody   recognises cisplatin 12intrastrand crosslinks  mtilby personal communication   figure     aa8 parental cell line was treated   increasing doses   cisplatin   1 h     linear increase     induction   cisplatin intrastrand adducts was observed   subsequent experiments 50 microm cisplatin   ic50 value     aa8 parent cell line was used     gave   readily measurable level   adducts 95 fmolmicrog dna   repair kinetics   cisplatin intrastrand crosslinks     aa8 parent cell line   shown   figure b following   1 h drug treatment   level   intrastrand adducts peaked after 4 h posttreatment incubation consistent   previous reports    24   48 h following drug removal 64   74     adducts were eliminated respectively figure  shows   posttreatment elimination   cisplatin 12intrastrand crosslinks     ner mutants   xpg mutant was most severely defective     elimination   these adducts   48 h following drug removal 37 times   intrastrand adduct remained     xpgdefective cells than   parent cell line   xpf   ercc1 mutants were also defective both 23fold     cisplatin icls     again striking       little correlation between ability   eliminate   cisplatin lesion   time   intrastrand crosslink   cellular sensitivity amongst ner mutants   extreme sensitivity     ercc1   xpf cell lines strongly suggests     have   dual deficiency   excision repair   another pathway vital     repair     tolerance   critical cisplatin dna adducts  importance   homologydriven recombination   response   cisplatin        evidence   homologous recombination plays   role     cellular response   cisplatin   lower organisms  therefore defects   recombination   well   ner may account     extreme cisplatin hypersensitivity   ercc1   xpf mammalian cells xrcc2 irs1   xrcc3 irs1sf cells defective   two rad51related recombination factors   derived     v79   aa8 parent cell lines respectively   xrs5 cells xrcc5 mutant cells defective     ku86 protein required   nonhomologous end joining nhej   derived   chok1 cells   cisplatin sensitivities   these mutants together   their parents   shown   figure  confirming published data    xrcc2   xrcc3 mutants showed extreme sensitivity   cisplatin having 50   38fold higher sensitivities compared   their parent cell lines fig     b respectively these values   similar   those obtained     xpf   ercc1 cells   contrast   nhej mutant xrs5 showed only   slight increase   sensitivity 17fold compared     parent cell line suggesting     involvement     nhej pathway     repair   cisplatin dna damage   minor fig c   scerevisiae   repair   psoralen   mechlorethamine induced dna icls involves   formation   dsbs   replicating cells  similarly   have clearly demonstrated   dsbs also arise   mammalian cho cells during processing   mechlorethamineinduced icls  however despite these suggestions   induction   dsbs during   processing   cisplatininduced dna damage has   been investigated   detail   address     induction   dsbs following cisplatin treatment was examined using pfge exponentially growing aa8 cells were treated   increasing doses   cisplatin   1 h   analysed   pfge dna   cells treated   an ic50 dose 15 microm   mechlorethamine nitrogen mustard was included     positive control   dsbs were observed following cisplatin treatment   150 microm three times   ic50 fig     expected   icls induced   nitrogen mustard resulted     accumulation   dsbs producing   lower molecular weight smear   dna released     plugs   investigate whether cisplatin dsbs arise over longer times aa8 cells were treated   100 microm cisplatin   1 h   dsbs were monitored over   0 24 h period   dsbs were observed   any     time points analysed fig b   xrcc2   xrcc3 homologous recombination mutants   highly sensitive   nitrogen mustard     correlates   an impaired ability   repair hn2induced dsbs  xrcc2   xrcc3 mutants   also extremely sensitive   cisplatin     level   induction   dsbs   cisplatin   very low         readily repaired   recombinationproficient aa8 cells     possible     pfge approach     sensitive enough   detect these dsbs     high sensitivity   xrcc2   xrcc3 mutants   cisplatin   associated   impaired repair   low levels   dsbs these mutants should accumulate dsbs following cisplatin treatment   investigate   possibility   induction   dsbs was examined     wildtype aa8   v79 xrcc2   xrcc3 mutants over   24 h time period following 1 h treatment   up   100 microm cisplatin these experiments failed   demonstrate   occurrence   any dsbs data   shown these results suggest   dsbs     occur     processing   cisplatininduced dna damage   contrast   other common agents   induce icls finally   determined whether   recombination mutant xrcc3 irs1sf   competent   initiate icl repair specifically     crosslink uncoupling stage cells were treated   50 microm cisplatin   1 h   icl uncoupling followed during 72 h posttreatment incubation   complete medium using   modified comet assay xrcc3 cells were defective     uncoupling   icls fig c   surprising result indicates     uncoupling stage   cisplatin icl repair might   dependent upon   formation   early recombination intermediates   contrasts   nitrogen mustard where xrcc3defective cells have been shown     capable   incising   icls induced     agent   figure 1   cisplatin sensitivity   parental aa8 cells   ner mutants xpb uv23 xpd uv42 xpf uv47 ercc1 uv96   xpg uv135  cisplatin sensitivity   parental aa8 cells   ner mutants xpb uv23 xpd uv42 xpf uv47 ercc1 uv96   xpg uv135 exponentially growing cells were treated   increasing concentrations   cisplatin   1 h incubated   drugfree medium   3 days   stained   srb fraction   growth inhibition was calculated   each dose   described   materials   methods   results     means     least three independent experiments   error bars show   standard error     mean figure 2     decrease   comet tail moment tm   increasing concentration   cisplatin    decrease   comet tail moment tm   increasing concentration   cisplatin aa8 cells were treated   increasing doses   cisplatin   1 h   analysed immediately   each drug concentration   tm   50 comets was measured     mean values were calculated   percentage decrease   tm   comparison   untreated samples was   calculated materials   methods   results shown above     means   three independent experiments   error bars show   standard error     mean b   early repair kinetics   icl repair   aa8 cells treated   50 microm cisplatin   1 h   samples removed   increasing times   comet analysis   results presented     means     least three independent experiments   error bars show   standard error     mean c induction   repair   cisplatin icls   parental   ner mutant cell lines wt aa8 xpb uv23 xpg uv135 xpf uv47   ercc1 uv96 cells were treated   50 microm cisplatin   1 h   incubated   drugfree medium   24 48   72 h   allow repair percentage decrease   tm   comparison   untreated samples was calculated   above   results presented     means     least three independent experiments   error bars show   standard error     mean figure 3     induction   cisplatin intrastrand crosslinks following treatment   aa8 cells   increasing doses   cisplatin    induction   cisplatin intrastrand crosslinks following treatment   aa8 cells   increasing doses   cisplatin exponentially growing aa8 cells were treated   cisplatin   1 h     level   intrastrand adducts were analysed immediately using competitive elisa b kinetics   cisplatin intrastrand adduct removal   aa8 cells exponentially growing aa8 cells were treated   50 microm cisplatin   1 h incubated   drugfree medium     stated times     level   intrastrand adducts quantified using competitive elisa   results     means   five independent experiments     error bars show   standard error     mean figure 4   elimination   cisplatin intrastrand crosslinks   wildtype aa8 cells   ner mutants xpg uv135 xpf uv47   ercc1 uv96  elimination   cisplatin intrastrand crosslinks   wildtype aa8 cells   ner mutants xpg uv135 xpf uv47   ercc1 uv96 cells were treated   50 microm cisplatin   1 h   adduct levels quantified immediately following drug removal 0 h   24   48 h later using competitive elisa   results presented     means   between three   five individual experiments   error bars     standard error     mean figure 5   cisplatin sensitivity   cho recombination mutants  cisplatin sensitivity   cho recombination mutants   xrcc2 irs1   its parental cell line v79 b xrcc3 irs1sf   parental aa8 cells c   nhej mutant xrcc5 xrs5   its parental cell line chok1 cells were treated   increasing concentrations   cisplatin   1 h incubated   drugfree medium   3 days   stained   srb   results     means     least three independent experiments   error bars     standard error     mean figure 6     pfge analysis   dna   cells treated   increasing doses   cisplatin    pfge analysis   dna   cells treated   increasing doses   cisplatin exponentially growing aa8 cells were treated     stated concentrations   cisplatin   15 microm nitrogen mustard   1 h   immediately analysed     presence   dsbs   pulsed field gels b pfge analysis   dna   cisplatintreated cells subject   further posttreatment incubation exponentially growing aa8 cells were treated   100 microm cisplatin   1 h   incubated   drugfree medium     stated time prior   pfge analysis lane c contained dna   mock treated cells subject   24 h posttreatment incubation c icl uncoupling   recombinationdefective cells irs1sf xrcc3 mutant cells   their isogenic parent aa8 were treated   50 microm cisplatin   1 h   incubated   drugfree medium   24 48   72 h   allow repair percentage decrease   tm   comparison   untreated samples was calculated   above   results presented     means     least three independent experiments   error bars show   standard error     mean
12202770.txt 6   has been established   both ner   homologydriven recombination activities   important     elimination   cisplatin dna adducts   escherichia coli    yeast  cells   agreement   previous reports    results obtained     study confirm   xpf   ercc1defective mammalian cells   extremely sensitive   cisplatin   contrast   other ner mutants considered here xpb xpd xpg   csb     possess   extreme sensitivity    implies     xpf ercc1 structurespecific nuclease plays   key role     repair   critical cisplatin lesions   repair intermediates   address whether   excision repair     particular lesion   specifically reduced   absent   xpf   ercc1defective cells   have measured   capacity     set   ner mutants   eliminate two cisplatin adducts   constitute critical dna damage induced     agent   icl   12intrastrand crosslink both   highly sensitive xpf   ercc1 mutants     slightly sensitive xpb   xpg mutants were defective     uncoupling   icls indicating     full complement   ner proteins   required     excision   cisplatin icls   clear correlation was observed between cellular sensitivity   icl uncoupling capacity although   xpb   xpg mutants were completely defective     uncoupling step   icl repair   were only 14   31fold   sensitive   cisplatin than   parent cell line compared     37 40fold increase   sensitivity observed   xpf   ercc1 mutants meyn et al  demonstrated   another ercc1 mutant cho cell line uv20 was extremely sensitive   cisplatin   defective     uncoupling   interstrand crosslinks     was taken   demonstrate   direct relationship between sensitivity   icl repair however   icl repair capacity     less sensitive nerdefective cell lines was   investigated here     first time   show     addition   xpf ercc1 other components     ner machinery   essential     excision   cisplatin icls   vivo   data suggest   icls       themselves   critical dna lesion induced   cisplatin since an inability   repair   lesion only leads     very modest increase   cellular sensitivity these results   very different   those obtained   nitrogen mustard  where   direct correlation between mutant sensitivity     ability   uncouple icls was evident     case   xpb   xpg cells were only slightly drug sensitive   were proficient     uncoupling   nitrogen mustardinduced icls whereas   highly sensitive xpf   ercc1 cells were severely defective   addition recent biochemical studies employing purified proteins  have shown     uncoupling step   psoralen icl repair can   achieved     xpf ercc1 nuclease     absence   other factors except rpa     former study   further crosslinkspecific excision reaction has been identified   bessho et al  here   complete human excision nuclease makes dual incisions 5     psoralen crosslink   one strand     damaged dna only although   authors state     intermediate might act   an initiation signal   recombination such   reaction does   release   crosslink   therefore probably does   represent   uncoupling reactions seen     study further biochemical studies employing defined cisplatin iclcontaining substrates   required   elucidate   molecular nature     reaction   surprising observation was     xrcc2   xrcc3 mutants were unable   uncouple   cisplatin icls fig c   raises   possibility   homologous recombination   initiated prior     incisions   uncouple   cisplatin crosslink       incision reactions depend upon an early recombination intermediate being formed perhaps   homology search requiring   rad51 family   proteins   includes xrcc2   xrcc3 precedes   uncoupling reaction while     possible   should   emphasised   studies     enzymology   mammalian homologous recombination have yet   identify such reactions nevertheless given     uncoupling incisions   cisplatin icls appear significantly different   those observed   nitrogen mustard icls   coordination might help explain   differing requirements   ner proteins     uncoupling step   removal   cisplatin 12intrastrand crosslinks was reduced       ner mutants tested   results   consistent   those obtained using purified proteins   reconstitute   excision repair   cisplatin intrastrand crosslinks   defined substrates     showed   xpg ercc1   xpf mutant cell lines were   significantly defective     repair     class   adduct again   absence     correlation between sensitivity   excision repair capacity   apparent   strongly suggests     ercc1 xpf complex plays an additional role     repair   cisplatin dna damage confirming published data  xrcc2   xrcc3 mutants were extremely sensitive   cisplatin demonstrating   homologydriven recombination plays   major role     repair   cisplatin dna damage several other emerging homologous recombination components including rad51 brca1   brca2 have also been implicated     mammalian response   cisplatin dna damage     mutations   these genes render cells sensitive   cisplatin brca1 promotes assembly   subnuclear rad51 foci following treatment   mouse embryonic stem cells   cisplatin    recently generated rad51 family mutant rad51b    derived   chicken dt40 cells shows hypersensitivity   cisplatin  ercc1   xpf must   also   considered   candidates     role     recombinational processing   cisplatin adducts   recent study   zdraveski et al  demonstrated   ecoli mutants defective   both daughterstrand gap   dsb homologous recombination pathways   sensitive   cisplatin providing evidence   dsbs may arise during   repair   cisplatin icls     organism surprisingly however   dsb formation was observed during   processing   cisplatininduced dna damage     study even   xrcc2   xrcc3 cells previous studies     laboratory     work   others has indicated     induction   dsbs   psoralen   nitrogen mustard icls might   due     collapse   replication forks  significantly mammalian cells possess enzymes able   replicate dna containing cisplatin adducts dna polymerase beta can perform extensive bypass synthesis   platinated dna   vitro    dna polymerase eta     defective   xpv patients can also bypass cisplatin intrastrand crosslinks efficiently     high fidelity  therefore   absence   dsbs following cisplatin treatment could     result     bypass   cisplatin adducts   indicate   when replication forks encounter cisplatin crosslinks dsbs     result     conceivable     ercc1 xpf nuclease plays some role     stage perhaps     recombinational restart   replication collectively these studies show   ercc1   xpf   vital     mammalian cell response     important anticancer agent   appears     major contribution made   these factors   largely independent   their role   excision repair     highly unlikely   an additional   yet uncharacterised critical cisplatin adduct exists   relies entirely upon xpf ercc1   repair future work   focus   identifying defects   cisplatininduced recombination pathways   endpoints resulting   loss   ercc1   xpf defined intrachromosomal repeat recombination substrates have already proved valuable   defining spontaneous recombination defects   ercc1   xpf cells      use   these constructs     analysis   recombination events induced   different dnadamaging agents     requirement   individual mammalian recombination factors should   explored   mechanisms     homologydriven recombination pathways process cisplatin lesions need     elucidated since   ability   selectively sensitise cells   cisplatin   inhibiting   pathway could substantially enhance   therapeutic efficacy     drug
12202770.txt 7 
